Shares of Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP – Get Free Report) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.15 and traded as low as $0.13. Elite Pharmaceuticals shares last traded at $0.13, with a volume of 376,968 shares.
Elite Pharmaceuticals Price Performance
The company has a current ratio of 1.94, a quick ratio of 1.19 and a debt-to-equity ratio of 0.08. The firm has a market cap of $138.54 million, a PE ratio of 12.98 and a beta of -0.16. The stock has a 50 day simple moving average of $0.15 and a 200-day simple moving average of $0.15.
Elite Pharmaceuticals Company Profile
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Further Reading
- Five stocks we like better than Elite Pharmaceuticals
- How is Compound Interest Calculated?
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Options Trading – Understanding Strike Price
- Hilton Demonstrates Asset Light is Right for Investors
- The How and Why of Investing in Biotech Stocks
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
